These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30235541)
1. A Practical Guide to Data Monitoring Committees in Adaptive Trials. Sanchez-Kam M; Gallo P; Loewy J; Menon S; Antonijevic Z; Christensen J; Chuang-Stein C; Laage T Ther Innov Regul Sci; 2014 May; 48(3):316-326. PubMed ID: 30235541 [TBL] [Abstract][Full Text] [Related]
2. Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive Trials. Antonijevic Z; Gallo P; Chuang-Stein C; Dragalin V; Loewy J; Menon S; Miller ER; Morgan CC; Sanchez M Ther Innov Regul Sci; 2013 Jul; 47(4):495-502. PubMed ID: 30235521 [TBL] [Abstract][Full Text] [Related]
3. Issues in data monitoring and interim analysis of trials. Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA; Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038 [TBL] [Abstract][Full Text] [Related]
4. On the independence of data monitoring committee in adaptive design clinical trials. Chow SC; Corey R; Lin M J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119 [TBL] [Abstract][Full Text] [Related]
5. Responsibilities of Data Monitoring Committees: Consensus Recommendations. Bierer BE; Li R; Seltzer J; Sleeper LA; Frank E; Knirsch C; Aldinger CE; Levine RJ; Massaro J; Shah A; Barnes M; Snapinn S; Wittes J Ther Innov Regul Sci; 2016 Sep; 50(5):648-659. PubMed ID: 30231760 [TBL] [Abstract][Full Text] [Related]
6. The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsors. Bhattacharyya A; Gallo P; Crisp A; LaVange L; Molenberghs G; Pétavy F; Seltzer J Biom J; 2019 Sep; 61(5):1232-1241. PubMed ID: 30589102 [TBL] [Abstract][Full Text] [Related]
7. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study. Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484 [TBL] [Abstract][Full Text] [Related]
8. Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials. Fleming TR; Hennekens CH; Pfeffer MA; DeMets DL J Biopharm Stat; 2014; 24(5):968-75. PubMed ID: 24926941 [TBL] [Abstract][Full Text] [Related]
10. Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases. Filippatos GS; de Graeff P; Bax JJ; Borg JJ; Cleland JG; Dargie HJ; Flather M; Ford I; Friede T; Greenberg B; Henon-Goburdhun C; Holcomb R; Horst B; Lekakis J; Mueller-Velten G; Papavassiliou AG; Prasad K; Rosano GM; Severin T; Sherman W; Stough WG; Swedberg K; Tavazzi L; Tousoulis D; Vardas P; Ruschitzka F; Anker SD Eur J Heart Fail; 2017 Apr; 19(4):449-456. PubMed ID: 28271595 [TBL] [Abstract][Full Text] [Related]
11. Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study. Hinga A; Ibrahim A; Vintimilla D; Jones M; Eckstein L; Rid A; Shah SK; Kamuya D BMJ Glob Health; 2024 Aug; 9(8):. PubMed ID: 39182924 [TBL] [Abstract][Full Text] [Related]
12. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative. Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947 [TBL] [Abstract][Full Text] [Related]
13. Data monitoring committees for multicenter clinical trials sponsored by the National Institutes of Health. I. Roles and membership of data monitoring committees for trials sponsored by the National Eye Institute. Hawkins BS Control Clin Trials; 1991 Jun; 12(3):424-37. PubMed ID: 1651212 [TBL] [Abstract][Full Text] [Related]
14. Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials. Sydes MR; Spiegelhalter DJ; Altman DG; Babiker AB; Parmar MK; Clin Trials; 2004 Feb; 1(1):60-79. PubMed ID: 16281463 [TBL] [Abstract][Full Text] [Related]
15. Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov. Bothwell LE; Avorn J; Khan NF; Kesselheim AS BMJ Open; 2018 Feb; 8(2):e018320. PubMed ID: 29440155 [TBL] [Abstract][Full Text] [Related]
16. Stakeholders' Perspectives on Current Issues in Data Monitoring Committees. Cartwright MJ; Friede T; Lawrence D; May E; Mütze T; Roes K Biom J; 2024 Oct; 66(7):e202300384. PubMed ID: 39308116 [TBL] [Abstract][Full Text] [Related]
17. An Estimate of the Benefit-Cost Impact of the FDA Guidance on Data Monitoring Committees. Seltzer J Ther Innov Regul Sci; 2015 Sep; 49(5):698-705. PubMed ID: 30227033 [TBL] [Abstract][Full Text] [Related]
18. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials. Fernandes RM; van der Lee JH; Offringa M BMC Pediatr; 2009 Dec; 9():77. PubMed ID: 20003383 [TBL] [Abstract][Full Text] [Related]
19. Presenting Risks and Benefits: Helping the Data Monitoring Committee Do Its Job. Evans SR; Bigelow R; Chuang-Stein C; Ellenberg SS; Gallo P; He W; Jiang Q; Rockhold F Ann Intern Med; 2020 Jan; 172(2):119-125. PubMed ID: 31739312 [TBL] [Abstract][Full Text] [Related]